<DOC>
	<DOCNO>NCT01654809</DOCNO>
	<brief_summary>The purpose study observe adverse reaction ratio hemagglutination inhibition ( HI ) antibody positive rate , Geometric mean titer ( GMT ) three brand split influenza virus vaccine different population .</brief_summary>
	<brief_title>Safety Immunogenicity Study Split Influenza Virus Vaccine Different Age Groups</brief_title>
	<detailed_description>Observational Objectives : To describe safety evaluate vaccine , give two-dose schedule accordance Package Insert , child age ≥ 6 month ≤ 36 months,6th 12th birthday ≥ 60th birthday . To describe immunogenicity evaluate vaccine , give two-dose schedule accordance Package Insert , child age ≥ 6 month ≤ 36 month , 6th 12th birthday ≥ 60rd birthday .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>participant enrol ( toddler : 6 month 3 year ; schoolaged child : 6 12 year old adult : ≥60 years） Eligible participant generally healthy stable chronic medical condition ( old adult ) History allergic reaction component study vaccine previous influenza vaccine History systemic hypersensitivity hen ' egg History Guillain Barré syndrome follow administration influenza vaccine Any immunodeficient immunocompromised condition Receipt cytotoxic immunosuppressive drug within past 6 month Receipt bloodderived product within past 3 month Receipt vaccine within one month prior study entry exception paediatric routine vaccination Receipt nonstudy 20102011 seasonal TIV Participation study nonapproved drug study Acute febrile disease selflimiting illness temporary exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>